Chinese companies kneel to the government.

A speculative list of JSE stocks with the list of traits that could make them consider delisting.

Viv Govender of Rand Swiss on the market's reaction to the budget. AECI CEO Mark Dytor unpacks their results as geographic diversification pays off and Adcock Ingram's CEO, Andy Hall, talks results showing healthcare continues to struggle under the pandemic.

The hit was somewhat cushioned by strong demand for immunity-boosting products.

Diversification across sectors is the best hedge against bad luck, stresses Keith McLachlan from Alpha Asset Management.

There is something deeply wrong with the stock market, and it appears systemic.

Mia Kruger of Kruger International on Stadio's results and the new PSG 3.0. Henry Laas, Murray and Roberts CEO, on the pandemic pushing the company into a loss. Linebooker CEO, Naude Rademan, talks ARC taking a stake in the business.

On weak outlook.

And Sun International faces unsolicited bid.

Adcock gave no financial details of the acquisition.

The coronavirus outbreak is number one on Bidvest's risk profile – CEO.

CEO Andy Hall explains issues related to pricing flexibility, wages, import costs, efficiency, being debt-free, and the outlook for unregulated acquisitions.

Group Five attempts to save internal jobs, Old Mutual, RCL Foods and Bidvest results and more.

The company performed strongly despite weaker consumer sentiment.

Stocks lifted by positive earnings